Abstract:Background: IBS and IBD are chronic gastrointestinal (GI) conditions associated with abdominal pain and abnormal bowel habits.Although IBS and IBD share common symptoms, their pathogenesis differs.Whereas IBD symptoms often arise from inflammatory or structural abnormalities, these objective markers are not consistently identified in IBS.Because symptom pathogenesis differs between disorders, we aimed to test whether symptom severity also varies between IBS and IBD.Methods: We compared GI symptoms using items developed for the NIH Patient Reported Outcome Measurement Information System (PROMIS®) that assessed frequency, severity, interference, and bother to 3 groups: (1) IBS patients from clinic and community populations, (2) IBD clinic patients, and (3) a U.S. general population (GP) sample selected by a commercial research firm (Cint) to approximate characteristics in the 2010 census.We measured 8 GI symptom domains: gastroesophageal reflux (GERD), disrupted swallowing, nausea/vomiting (N/V), belly pain, diarrhea, constipation, gas/bloating, and fecal incontinence/soling (FI).We measured overall symptom severity by averaging responses to items and transforming linearly to a 0-100 possible range (higher=worse).We compared group differences using analysis of covariance controlling for demographics and GI symptom-specific anxiety (Visceral Sensitivity Index [VSI]).To adjust for multiple comparisons for different symptoms, a p ,0.01 was used.Results: Respondents included 231 with IBS (mean age=44.8yrs; 68%F; 56.3% Caucasian), 190 with IBD (mean age=41.3yrs; 46%F; 58.4% Caucasian) and 1117 from the GP (mean age 45.7; 57%F; 72.7% Caucasian).Mean age, race/ethnicity, and education significantly differed between groups (all p ,0.01).The Table shows differences in GI symptom severity scores between groups.The GP had greater severity of GERD, disrupted swallowing and N/V compared to the patient groups.GERD severity differed among all groups with greatest severity in GP, followed by IBS, and then IBD.GP reported more disrupted swallowing than IBS and greater N/V than IBD.IBS patients reported greater severity of belly pain vs. GP and greater severity of constipation and gas/ bloating vs. GP and IBD.IBD patients had more severe diarrhea than the GP but not IBS.Conclusions: While IBS and IBD are conditions associated with greater lower GI symptom severity compared to the GP, they report less severe upper GI symptoms.Between disease states, IBS patients report numerically worse symptom severity vs. IBD for 7 of 8 GI symptom domains -only diarrhea appeared more severe in IBD.Although IBD is marked by objective inflammatory and anatomic biomarkers, this does not necessarily yield worse symptom severity than IBS -a condition without reliable biomarkers; the converse is true in this study.* P values after controlling for demographics and VSI.Values shown in bold are statistically significant.

Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC).

A Population-Based Survey of the Epidemiology of Symptom-Defined Gastroesophageal Reflux Disease: the Systematic Investigation of Gastrointestinal Diseases in China

Epidemiological Study of Symptomatic Gastroesophageal Reflux Disease in China: Beijing and Shanghai

Risk Factors for Gastroesophageal Reflux Disease, Reflux Esophagitis and Non-Erosive Reflux Disease among Chinese Patients Undergoing Upper Gastrointestinal Endoscopic Examination

Epidemiological investigation in outpatients with symptomatic gastroesophageal reflux from the Department of Medicine in Zhejiang Province, east China

Systematic Investigation of Gastrointestinal Diseases in China (SILC): Validation of Survey Methodology.

Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China.

Helicobacter pylori infection and gastritis: the Systematic Investigation of gastrointestinaL diseases in China (SILC).

Epidemiology of gastroduodenal erosions in the general population: endoscopic results of the systematic investigation of gastrointestinal diseases in China (SILC).

Systematic Review: Patterns of Reflux-Induced Symptoms and Esophageal Endoscopic Findings in Large-Scale Surveys

Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact: Dyspepsia and irritable bowel syndrome in China

Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi'an of Northwest China.

Clinical Characteristics of 326 Cases of Erosive Esophagitis in Healthy Population Undergoing Health Check-Up in Eastern Zhejiang Province

Prevalence Of, and Factors Associated With, Gastroesophageal Reflux Disease: A Population-Based Study in Shanghai, China

Epidemiologic study on symptomatic gastroesophageal reflux disease and its risk factors in outpatient populations of internal medicine in Zhejiang province

Validation of a survey methodology for gastroesophageal reflux disease in China

Tu2066 Prevalence of Irritable Bowel Syndrome in China: Joint Effects of Psychiatric Morbidity with Life Event Stress and Lactose Intake

Survey of nocturnal reflux in patients with gastroesophageal reflux disease in China.

Gastroesophageal Reflux Disease Questionnaire (gerdq) in Real‐world Practice: A National Multicenter Survey on 8065 Patients

Chronic gastritis in China: a national multi-center survey

An epidemiological survey of gastroesophageal reflux disease at the digestive endoscopy center in Guangzhou